Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Taysha Gene Therapies Inc
(NQ:
TSHA
)
2.470
+0.290 (+13.30%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Taysha Gene Therapies Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
2 Healthcare Stocks That More Than Tripled Recently. Can They Keep Climbing?
September 19, 2023
These highly volatile stocks recently rocketed higher, but what are the chances that they'll be able to provide further gains?
Via
The Motley Fool
Manchester United, Trip.com Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
September 05, 2023
U.S. stock futures traded higher this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
3 Small-Cap Stocks to Sell in September Before They Crash & Burn
September 04, 2023
A lot of speculative companies enjoyed strong rallies in the summer. Sell these three small-cap stocks before it's too late.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 29, 2023
Via
Benzinga
Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 29, 2023
Gainers Axcella Health Inc. (NASDAQ: AXLA) shares climbed 196% to $0.3335 after the company announced it was granted a patent for long COVID fatigue treatment.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
PDD Holdings, UP Fintech Holding, Big Lots And Other Big Stocks Moving Higher On Tuesday
August 29, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Ideanomics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
August 28, 2023
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 24, 2023
Via
Benzinga
Around $15M Bet On Taysha Gene Therapies? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
August 17, 2023
The Dow Jones closed lower by around 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What 6 Analyst Ratings Have To Say About Taysha Gene Therapies
August 15, 2023
Via
Benzinga
Why Taysha Gene Therapies Stock Is Surging
August 14, 2023
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) shares are surging higher Monday.
Via
Benzinga
What 4 Analyst Ratings Have To Say About Taysha Gene Therapies
June 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 15, 2023
Via
Benzinga
Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket
August 15, 2023
Gainers Delcath Systems, Inc. (NASDAQ: DCTH) shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with...
Via
Benzinga
Exposures
Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 15, 2023
Pre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday!
Via
InvestorPlace
Analyst Ratings for Taysha Gene Therapies
May 12, 2023
Via
Benzinga
Recap: Taysha Gene Therapies Q1 Earnings
May 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 14, 2023
Via
Benzinga
Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher
August 14, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 90 points on Monday. The Dow traded down 0.14% to 35,232.62 while the NASDAQ rose 0.66% to 13,735.42. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
August 14, 2023
Via
Benzinga
US Stocks Turn Higher; BioXcel Therapeutics Shares Plummet
August 14, 2023
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 80 points on Monday. The Dow traded up 0.01% to 35,284.34 while the NASDAQ rose 0.64% to 13,732.05....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Preview: Taysha Gene Therapies
May 10, 2023
Via
Benzinga
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 14, 2023
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration...
Via
Benzinga
Dow Falls 50 Points; Monday.com Posts Upbeat Results
August 14, 2023
U.S. stocks traded mostly lower this morning, with the Dow Jones falling around 50 points on Monday. Following the market opening Monday, The Dow traded down 0.14% to 35,230.38 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 14, 2023
Via
Benzinga
Taysha Gene Therapies Touts Encouraging Preclinical Data From Rett Syndrome Candidate
May 19, 2023
Taysha Gene Therapies Inc (NASDAQ: TSHA) presented preclinical data from neonatal mouse models on TSHA-102 for Rett syndrome, including new data in wild-type mice, at the American Society of Gene and...
Via
Benzinga
FDA's Approval For Sarepta's Duchenne Gene Therapy, A Boost for Taysha Gene's Rare Neuropathy Treatment: Analyst Weighs
May 15, 2023
On Friday, the FDA's adcomm voted 8 to 6 in support of accelerated approval of Sarepta Therapeutics Inc's SRPT SRP-9001 (delandistrogene moxeparvovec) for ambulatory patients with
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 29, 2023
On Wednesday, 81 companies hit new 52-week lows.
Via
Benzinga
Earnings Scheduled For May 11, 2023
May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.